The timing of administration of exogenous glucocorticoid affects 24 hour growth hormone secretion in children. (August 2017)

• Record Type: Journal Article
• Authors: Wolthers, Ole D.; Ramshanker, Nilani; Heuck, Carsten; Frystyk, Jan
• Is Part Of: Growth hormone & IGF research. Volume 35(2017)
• Page Start: 40
• Page End: 44
• Publication Date: 2017-08
• Subjects: Growth hormone -- Prednisolone -- Glucocorticoids -- Administration regimen -- Growth -- Children -- Asthma; Growth regulators -- Periodicals; Growth -- Regulation -- Periodicals; Somatomedin -- Periodicals; Somatomedins -- Periodicals; Growth Hormone -- Periodicals; Growth Substances -- Periodicals; Croissance -- Régulation -- Périodiques; Croissance -- Régulateurs -- Périodiques; Somatotrophine -- Périodiques; Somatomédine -- Périodiques; Growth -- Regulation; Growth regulators; Electronic journals; Periodicals; Electronic journals; 612.4
• DOI: 10.1016/j.ghir.2017.06.004
• Languages: English
• ISSNs: 1096-6374

Abstract

Abstract: Exogenous glucocorticoids may suppress linear growth by affecting the diurnal secretory rhythm of GH. Objective: To assess whether the timing of exogenous glucocorticoid administration affects GH secretion in children. Design: Four girls and four boys aged 10.6 to 15.8 (mean 13.2) years with normal weight and height and pubertal stages I–IV were studied in an open randomized 2-period cross-over trial, with a 1-day un-in, and two 4-day periods of 5 mg prednisolone in the morning or in the evening, respectively, separated by a 3-week washout period. At run-in and on the last day of each treatment period serum was collected every 20 min for 24 h for assessment of GH. Secondary analyses were serum levels of IGF-I and IGFBP-3 (measured every 8 h), and IGFBP-1, insulin, and collagen markers PICP, PINP, ICTP and PIIINP (measured every 2 h). Results: Evening prednisolone suppressed 24 hour GH secretion ( P = 0.016), overnight GH secretion ( P = 0.023) and IGF-I ( P = 0.024) when compared to morning prednisolone, but not when compared to run-in. Evening prednisolone also increased nocturnal insulin levels as compared to run-in ( P = 0.010). Irrespective of time of day, prednisolone increased serum collagen markers PICP, PIINP, ICTP and PINP (all P < 0.05). Conclusions: Short-term prednisolone 5 mg administered in the morning may alleviate nocturnal GH suppression as compared to evening administration. In analogy, growth rates are less affected by morning as compared to evening administration of exogenous glucocorticoids. In contrast, collagen markers and metabolic indices were not affected by the timing of prednisolone administration. Highlights: Ten children in an open randomized 2-periods cross-over trial were given 5 mg prednisolone in the morning or in the evening. At run-in and on the last day of each treatment period blood was collected every 20 min for 24 hours for assessment of GH. Evening prednisolone suppressed 24 hours GH secretion, whereas morning administration did not. Prednisolone administered in the morning may alleviate nocturnal GH suppression as compared to evening administration in children.